270 related articles for article (PubMed ID: 27013200)
1. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.
Mo D; Fang H; Niu K; Liu J; Wu M; Li S; Zhu T; Aleskandarany MA; Arora A; Lobo DN; Madhusudan S; Balajee AS; Chi Z; Zhao Y
Cancer Res; 2016 May; 76(10):3057-66. PubMed ID: 27013200
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
3. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
Liu D; Ke J; Liu Y; Rao H; Tang Z; Liu Y; Zhang Z; You L; Luo X; Sun Z; He Z; Li F; Qiu Z; Hu J; Mbadhi MN; Tang J; Wu F; Li S
Mol Carcinog; 2021 Dec; 60(12):813-825. PubMed ID: 34499772
[TBL] [Abstract][Full Text] [Related]
4. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.
Zhou F; Wang L; Jin K; Wu Y
Bioengineered; 2021 Dec; 12(1):5859-5869. PubMed ID: 34477047
[TBL] [Abstract][Full Text] [Related]
5. Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells.
Song W; Jiang R; Zhao CM
Asian Pac J Cancer Prev; 2012; 13(11):5619-25. PubMed ID: 23317227
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
Huang YS; Xue Z; Zhang H
Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
[TBL] [Abstract][Full Text] [Related]
8. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
Tang T; Song X; Liu YF; Wang WY
Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
11. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.
Zhao H; Zhao D; Jin H; Li H; Yang X; Zhuang L; Liu T
Mol Med Rep; 2016 Aug; 14(2):1817-22. PubMed ID: 27357249
[TBL] [Abstract][Full Text] [Related]
12. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
13. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.
Park J; Ko YS; Yoon J; Kim MA; Park JW; Kim WH; Choi Y; Kim JH; Cheon Y; Lee BL
Gastric Cancer; 2014; 17(3):423-30. PubMed ID: 24202965
[TBL] [Abstract][Full Text] [Related]
14. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
Cui Y; Yang F; He L
Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
Xu HB; Shen FM; Lv QZ
Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
[TBL] [Abstract][Full Text] [Related]
20. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.
Zhou L; Wu Y; Guo Y; Li Y; Li N; Yang Y; Qin X
Cancer Invest; 2017 May; 35(5):289-300. PubMed ID: 28368679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
